Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.631
+0.001 (0.19%)
At close: Mar 9, 2026, 4:00 PM EDT
0.634
+0.003 (0.46%)
After-hours: Mar 9, 2026, 8:00 PM EDT
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $13.14 million as of March 9, 2026. Its market cap has decreased by -27.89% in one year.
Market Cap
13.14M
Enterprise Value
7.57M
1-Year Change
-27.89%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $13.14M, a decrease of -60.64%. That is a compound annual growth rate of -47.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 13.12M | -11.28% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 13.92M |
| Curis | 13.56M |
| Quantum BioPharma | 13.38M |
| Jupiter Neurosciences | 13.32M |
| OSR Holdings | 13.18M |
| Traws Pharma | 12.79M |
| BioLineRx | 12.68M |
| NewcelX | 12.63M |